Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study

Author： Gümüşş Mahmut   Davidson Neville   Bauknecht Thomas   Soldatenkova Victoria   Benhadji Karim A  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.28, Iss.3, 2012-03, pp. : 401-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved Survival of Patients with Metastatic Breast Cancer in Routine Care: Results of a Retrospective Study in a Community-Based Oncology Group Practice 1995–2005

By  

Oncology Research and Treatment, Vol. 32, Iss. 3, 2009-02 ,pp. : 107-113

Karger

Access to resources Recommend Favorite

Mitomycin C in Combination with Vinorelbine in Anthracycline- and/or Taxane-Pretreated Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 500-504

Karger

Access to resources Recommend Favorite

Capecitabine and Mitomycin C Is an Effective Combination for Anthracycline- and Taxane-Resistant Metastatic Breast Cancer

By  

Oncology, Vol. 70, Iss. 4, 2006-10 ,pp. : 294-300

Karger

Access to resources Recommend Favorite

Outpatient Therapy in Metastatic Breast Cancer. A Retrospective Study of 90 Patients Treated in an Oncology Group Practice

By  

Oncology Research and Treatment, Vol. 27, Iss. 4, 2004-09 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

Taxane therapy for early stage breast cancer

By Nabholtz Jean-Marc   Gligorov Joseph  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 99-114

Future Medicine

Access to resources Recommend Favorite